Phibro Animal Health (NASDAQ:PAHC) Raised to Buy at StockNews.com

Phibro Animal Health (NASDAQ:PAHC) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.

A number of other equities research analysts have also recently weighed in on the company. Barclays boosted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. Morgan Stanley upped their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $21.00.

Phibro Animal Health Trading Up 3.7 %

NASDAQ PAHC opened at $21.25 on Friday. The firm’s fifty day moving average price is $22.57 and its 200 day moving average price is $22.59. Phibro Animal Health has a 12 month low of $12.05 and a 12 month high of $26.55. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The company has a market capitalization of $860.69 million, a price-to-earnings ratio of 44.27, a price-to-earnings-growth ratio of 0.45 and a beta of 0.58.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, sell-side analysts expect that Phibro Animal Health will post 1.95 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Phibro Animal Health

Several institutional investors have recently bought and sold shares of PAHC. Sterling Capital Management LLC lifted its stake in shares of Phibro Animal Health by 2.4% in the 4th quarter. Sterling Capital Management LLC now owns 18,762 shares of the company’s stock worth $394,000 after acquiring an additional 448 shares during the period. Rhumbline Advisers lifted its position in Phibro Animal Health by 0.6% in the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock valued at $1,608,000 after purchasing an additional 484 shares during the period. Los Angeles Capital Management LLC boosted its holdings in Phibro Animal Health by 2.1% in the 4th quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock valued at $505,000 after purchasing an additional 503 shares in the last quarter. BNP Paribas Financial Markets increased its position in Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after purchasing an additional 729 shares during the period. Finally, New York State Teachers Retirement System raised its stake in shares of Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after buying an additional 775 shares in the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.